- $546.63m
- $404.45m
- $418.63m
Brief: MiMedx Q1 Sales USD 58.991 Million Vs. IBES Estimate USD 65 Million
MiMedx beats Q4 sales estimates; announces $100 mln share buyback
Brief: MiMedx Q4 Sales USD 118.095 Million Vs. IBES Estimate USD 106.8 Million
MiMedx Q3 net sales beat estimates
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
MiMedx Q2 net sales up 13%, beat expectations
Brief: MiMedx Group Announces Strategic Collaboration With Vaporox, Inc.
MiMedx Group Inc reports results for the quarter ended March 31 - Earnings Summary
MiMedx Group Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: MiMedx Group Files Patent Infringement Lawsuit Against Surgenex
RCS - EW Healthcare Ptrs - EW Healthcare Partners’ Leadership Evolution
MiMedx Group Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: MiMedx Q3 Sales USD 84.057 Million Vs. IBES Estimate USD 82.7 Million
MiMedx Group Inc reports results for the quarter ended in June - Earnings Summary
Brief: MiMedx Q2 Sales USD 87.207 Million Vs. IBES Estimate USD 88.9 Million
MiMedx Group Inc expected to post earnings of 8 cents a share - Earnings Preview
Brief: Cassava Sciences Announces Changes in Executive Leadership
MiMedx Group Inc reports results for the quarter ended in March - Earnings Summary
Brief: MiMedx Q1 Sales USD 84.709 Million Vs. IBES Estimate USD 79.4 Million